Covestor LTD Repligen Corp Transaction History

Covestor LTD

$160 Million
Q4 2024

A detailed history of Covestor LTD transactions in Repligen Corp stock. As of the latest transaction made, Covestor LTD holds 125 shares of RGEN stock, worth $17,502. This represents 0.01% of its overall portfolio holdings.

Number of Shares

125

Previous 98 27.55%

Holding current value

$17,502

Previous $15,000 20.0%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$123.41 - $160.92 $3,332 - $4,344	27 Added 27.55%	125 $18,000
Q3 2024 Nov 01, 2024	BUY	$119.79 - $167.35 $3,114 - $4,351	26 Added 36.11%	98 $15,000
Q2 2024 Aug 09, 2024	SELL	$120.0 - $182.95 $35,400 - $53,970	-295 Reduced 80.38%	72 $9,000
Q1 2024 May 10, 2024	SELL	$170.78 - $208.42 $853 - $1,042	-5 Reduced 1.34%	367 $68,000
Q4 2023 Feb 09, 2024	SELL	$114.17 - $185.35 $36,306 - $58,941	-318 Reduced 46.09%	372 $67,000
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $20,123 - $25,593	-145 Reduced 17.37%	690 $110,000
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $19,240 - $25,063	139 Added 19.97%	835 $118,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $2,468 - $3,169	16 Added 2.35%	696 $117,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $7,633 - $10,366	47 Added 7.42%	680 $115,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $8,502 - $13,579	53 Added 9.14%	633 $118,000
Q2 2022 Aug 10, 2022	BUY	$140.68 - $188.02 $13,505 - $18,049	96 Added 19.83%	580 $94,000
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $28,853 - $46,174	179 Added 58.69%	484 $91,000
Q4 2021 Feb 10, 2022	BUY	$247.59 - $304.47 $75,514 - $92,863	305 New	305 $81,000

Others Institutions Holding RGEN

# of Institutions

482

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.77B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account